CEREP - Export company showcase @ B2B French Export Directory

Cerep’s mission is to provide pharmaceutical companies with high-quality services in drug discovery and drug development. Cerep provides solutions allowing faster and cost-effective drug discovery by identifying at early stages the most promising drug candidates as well as eliminating those compounds likely to fail in development.
Cerep offers preclinical drug discovery services for in vitro pharmacology, in vitro ADME-Tox & in vivo PharmacoKinetic.
Cerep has developed unique know-how based on technologies of in vitro screening and of profiling using its proprietary database BioPrint®, which allows the modeling of clinical effects of drug candidates from their molecular properties.
Cerep’s technologies benefit to more than 460 pharmaceutical and biotechnological companies worldwide including most of the top pharmaceutical firms.
Cerep’s next objective is to open satellite laboratories, closer to where compounds are synthesized and drug candidates optimized, thus further decreasing turnaround time for discovery teams to obtain data.

Legal Name	CEREP
Director Name	JEAN Thierry
French Legal Category	Limited liability company with board of directors
Registered capital (in Euros)	3 783 562
Year company founded	10/18/1999
Etablishment legal status	Limited liability company with board of directors
% Turnover from export	+70%
Related activities	Health, pharmacy, life sciences Pharmacy Services Services, others (R&D, postal services, etc.)

> French-Business-Home > Company : CEREP